These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15973420)

  • 1. Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli.
    Cornvik T; Dahlroth SL; Magnusdottir A; Herman MD; Knaust R; Ekberg M; Nordlund P
    Nat Methods; 2005 Jul; 2(7):507-9. PubMed ID: 15973420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient and generic strategy for producing soluble human proteins and domains in E. coli by screening construct libraries.
    Cornvik T; Dahlroth SL; Magnusdottir A; Flodin S; Engvall B; Lieu V; Ekberg M; Nordlund P
    Proteins; 2006 Nov; 65(2):266-73. PubMed ID: 16948159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for soluble expression of recombinant proteins in a 96-well format.
    Knaust RK; Nordlund P
    Anal Biochem; 2001 Oct; 297(1):79-85. PubMed ID: 11567530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colony filtration blotting for screening soluble expression in Escherichia coli.
    Dahlroth SL; Nordlund P; Cornvik T
    Nat Protoc; 2006; 1(1):253-8. PubMed ID: 17406241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A support vector machine-based method for predicting the propensity of a protein to be soluble or to form inclusion body on overexpression in Escherichia coli.
    Idicula-Thomas S; Kulkarni AJ; Kulkarni BD; Jayaraman VK; Balaji PV
    Bioinformatics; 2006 Feb; 22(3):278-84. PubMed ID: 16332713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined in-fermenter extraction and cross-flow microfiltration for improved inclusion body processing.
    Tin Lee C; Morreale G; Middelberg AP
    Biotechnol Bioeng; 2004 Jan; 85(1):103-13. PubMed ID: 14705017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free production of aggregation-prone proteins in soluble and active forms.
    Kang SH; Kim DM; Kim HJ; Jun SY; Lee KY; Kim HJ
    Biotechnol Prog; 2005; 21(5):1412-9. PubMed ID: 16209544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins.
    Thapa A; Shahnawaz M; Karki P; Raj Dahal G; Sharoar MG; Yub Shin S; Sup Lee J; Cho B; Park IS
    Biotechniques; 2008 May; 44(6):787-96. PubMed ID: 18476832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient solubilization of inclusion bodies.
    Freydell EJ; Ottens M; Eppink M; van Dedem G; van der Wielen L
    Biotechnol J; 2007 Jun; 2(6):678-84. PubMed ID: 17492713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of the recombinant membrane protein YidC: a case study for increased stability and solubility.
    Martinez Molina D; Lundbäck AK; Niegowski D; Eshaghi S
    Protein Expr Purif; 2008 Nov; 62(1):49-52. PubMed ID: 18586516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel flow cytometry-based method for analysis of expression levels in Escherichia coli, giving information about precipitated and soluble protein.
    Hedhammar M; Stenvall M; Lönneborg R; Nord O; Sjölin O; Brismar H; Uhlén M; Ottosson J; Hober S
    J Biotechnol; 2005 Sep; 119(2):133-46. PubMed ID: 15996784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli.
    Martínez-Alonso M; García-Fruitós E; Villaverde A
    Biotechnol Bioeng; 2008 Dec; 101(6):1353-8. PubMed ID: 18980180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ protein folding and activation in bacterial inclusion bodies.
    Gonzalez-Montalban N; Natalello A; García-Fruitós E; Villaverde A; Doglia SM
    Biotechnol Bioeng; 2008 Jul; 100(4):797-802. PubMed ID: 18351678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Gateway vector and expression protocol for fast and efficient recombinant protein expression in Mycobacterium smegmatis.
    Goldstone RM; Moreland NJ; Bashiri G; Baker EN; Shaun Lott J
    Protein Expr Purif; 2008 Jan; 57(1):81-7. PubMed ID: 17949993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic profiling of Escherichia coli proteins under high cell density fed-batch cultivation with overexpression of phosphogluconolactonase.
    Wang Y; Wu SL; Hancock WS; Trala R; Kessler M; Taylor AH; Patel PS; Aon JC
    Biotechnol Prog; 2005; 21(5):1401-11. PubMed ID: 16209543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput system for determining dissolution kinetics of inclusion bodies.
    Dürauer A; Mayer S; Sprinzl W; Jungbauer A; Hahn R
    Biotechnol J; 2009 May; 4(5):722-9. PubMed ID: 19288514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An automatable screen for the rapid identification of proteins amenable to refolding.
    Cowieson NP; Wensley B; Listwan P; Hume DA; Kobe B; Martin JL
    Proteomics; 2006 Mar; 6(6):1750-7. PubMed ID: 16475229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli.
    de Marco A
    Nat Protoc; 2007; 2(10):2632-9. PubMed ID: 17948006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble expression of archaeal proteins in Escherichia coli by using fusion-partners.
    Kim S; Lee SB
    Protein Expr Purif; 2008 Nov; 62(1):116-9. PubMed ID: 18657619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.